Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Brooks Laboratories Limited (NSE: BROOKS), ISIN INE650L01011 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
BROOKS last traded at ₹66.00 (+0.06%), with a 52-week range of ₹36.30 to ₹112.40 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 52.62%, FIIs 0.04%, DIIs 10.50%, mutual funds 9.90%.
EquiSense Score (ECS): 20/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.